A new Guide targeting potential life sciences investors for life sciences companies will be launched at networking events in Sydney and Melbourne – and registration is now open.
The Guide to Life Sciences Investing (the Guide) was developed for investors with little or no experience in the sector and outlines the factors particular to life sciences companies that potential investors should consider. It builds on general investment guidance and aims to equip potential investors with knowledge of the basic operations and products of life sciences companies, including the terminology, time lines and regulatory frameworks in the sector, as well as how securities trade on the market.
Join AusBiotech CEO Glenn Cross and guest speakers, including ASX Deputy CEO, Peter Hiom, and Sirtex Global Head of Investor Relations, Dr Tom Duthy, for the Sydney launch. In Melbourne, ASX Manager Listings, James Gerraty, and WILSONS Healthcare Analyst, Elyse Shapiro, will join Mr Cross to launch the Guide.
The Guide is one of the three main components of the MTPConnect-funded ‘Comprehensive Global Investment Program for the Australian Life Sciences Sector – companies, investors and researchers’ project. AusBiotech-led Program aims to improve management and workforce skills. AusBiotech is working with consortium partners ASX, DibbsBarker, WE Buchan and KPMG, all of which bring extensive insight and experience in the life sciences to enhance the capability of the sector to engage with international markets and access global supply chains.
This venture has received funding through the MTPConnect Project Fund Program – a dollar-for-dollar matched program investing in big, bold ideas to improve the productivity, competitiveness and innovative capacity of Australia’s medical technology, biotechnology and pharmaceutical sector, supported by the Australian Government Industry Growth Centres Initiative.